Webinar Replay: Finding the Right AML Treatment for Me

Published on

Topics include: Treatment | General , Treatment and Understanding

What is personalized medicine, and how can it help AML (acute myeloid leukemia) patients? Broadcasted live from the 2017 ASH (American Society of Hematology) meeting, Patient Power’s Andrew Schorr was joined by AML experts Dr. Gwen Nichols, Executive Vice President and Chief Medical Officer at The Leukemia & Lymphoma Society (LLS), Dr. Ross Levine, the Laurence Joseph Dineen Chair in Leukemia Research at Memorial Sloan Kettering Cancer Center, and Rick Ross, an AML patient advocate. The expert panel shared an overview of the AML news coming out of ASH, an update on personalized medicine options currently available and highlighted helpful resources for patients and their loved ones.

This is a Patient Empowerment Network program produced by Patient Power, in partnership with The Leukemia & Lymphoma Society (LLS). We thank Astellas, Celgene Corporation, Novartis, Pfizer and Seattle Genetics for their support.

View more programs featuring , , and

Produced in association with and

Related Programs

Webinar Replay: AML Genetic Testing and Me

Watch the webinar replay of AML Genetic Testing and Me, as an expert panel discusses essential genetic testing for AML patients.

Published:

Targeted Therapy: Finding the Right Treatment Option for Your AML

With several newly approved AML treatments, how do you know which is right for you? Dr. Michael Deininger discusses current AML medicines and ones on the horizon.

Published:

What are clinical trials and what can I expect if I enroll?

Prof. Alan Burnett from Cardiff University, Cardiff, UK describes the different phases of clinical trials and how they work.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on December 14, 2017